Abstract

BackgroundThe Kampo medicine bofutsushosan (BTS; Pulvis ledebouriellae compositae; Fang Feng Tong Sheng San) has been used as an anti-obesity treatment in overweight patients. In this study, we assessed the underlying physiological changes induced by BTS in obese mice maintained on a high-fat diet.MethodsMale ICR mice were fed a 60% kcal fat diet for 5 weeks starting at 4 weeks of age and then fed the same diet with administration of water (control) or aqueous BTS extract (1.0–2.0 g/kg) for 25 days. Body weight, wet weight of isolated white adipose tissue, and obesity-related serum parameters (glucose, lipids, leptin, adiponectin) were measured after treatment. The mRNA expression levels of leptin, adiponectin, and UCP1 in the adipose tissues were determined by quantitative real-time polymerase chain reaction after the first 5 days of treatment.ResultsBofutsushosan (1.5–2.0 g/kg) significantly decreased total body weight and total wet weight of white adipose tissue isolated from subcutaneous (retroperitoneal) and visceral regions (epididymal, mesenteric, and perirenal). At 2.0 g/kg, BTS also decreased total fat mass, visceral fat mass, and ratio of fat mass to body weight as measured by computed tomography, and significantly decreased epididymal adipocyte size after 14 and 25 days’ treatment. Twenty-five days’ treatment lowered serum glucose, insulin, leptin, and triglycerides, and reduced homeostasis model assessment-insulin resistance. Alternatively, 2.0 g/kg BTS significantly increased mRNA levels of adiponectin, leptin, and UCP1 in interscapular brown adipose tissue but not epididymal white adipose tissue after 5 days’ administration.ConclusionIn the early administration period, BTS increased mRNA expression levels of leptin, adiponectin, and UCP1 in brown adipose tissues. With longer administration, BTS improved insulin resistance, and subsequently reduced serum levels of leptin and triglyceride in parallel with decreased visceral white adipose tissue volume and adipocyte size.

Highlights

  • The Kampo medicine bofutsushosan (BTS; Pulvis ledebouriellae compositae; Fang Feng Tong Sheng San) has been used as an anti-obesity treatment in overweight patients

  • We investigated the effects of BTS on the mRNA expression levels of UCP1, adiponectin, and leptin in adipose tissue, as well as insulin resistance, serum triglycerides, white adipocyte size, and white adipose tissue weight in high-fat diet-fed obese model mice

  • At day 25, Body weight was significantly reduced in the obese mouse group administered 2.0 g/kg BTS compared to the water-administered control group [45.9 ± 3.8 g (n = 7) vs. 59.0 ± 9.5 g (n = 6), P < 0.05] but not in groups receiving 1.0 or 1.5 g/ kg BTS [55.9 ± 8.5 g (n = 8) and 48.0 ± 4.6 g (n = 6)]

Read more

Summary

Introduction

The Kampo medicine bofutsushosan (BTS; Pulvis ledebouriellae compositae; Fang Feng Tong Sheng San) has been used as an anti-obesity treatment in overweight patients. We assessed the underlying physiological changes induced by BTS in obese mice maintained on a high-fat diet. Obesity rates are increasing worldwide [1], resulting in progressively greater incidences of associated health problems such as type 2 diabetes mellitus, ischemic heart disease, stroke, and cancer. Obesity results from an imbalance between food intake and energy consumption (basal metabolism and volitional energy expenditure). Foods that are rich in fats increase body weight induce diabetes in mice and rats [3]. Many studies have characterized the pathological responses of animals to high-fat diets [4, 5]. The pathogenesis of obesity is complex; the key factor is long-term deregulation of energy balance due to increased energy intake and/or reduced energy expenditure.

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call